rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

The company

Tiziana Life Sciences Ltd - Common Shares

TLSA · Nasdaq

Health CareBiotechnologyNot moving yet

TLSA stood above a rising 150-day average in 4 of the last 52 weekly readings, and has been out of that trend for the last 46 weeks. It is 13.5% below that average now. Biotechnology: 16% of its 561 stocks in an uptrend (−15 points in four weeks); Health Care: 26% (−10 points in four weeks).

Statistics

Rotation
Not moving yet
Weeks in an uptrend
out for 46
Industry in uptrend
16% -15 in 4 wk
Insider buys, 12 months
$2.1M
Insider sales, 12 months
$0
Officials’ trades on record
0
Institutions holding
31 (-1)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 4 of 52 weeks.

20 Apr – 19 Oct
17%28%39%Apr 26Jun 26Jul 26Sep 26Oct 26

Biotechnology: Few of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.

Money in and out

1 Nov 2024 – 1 Oct 2026
$0$1.9MNov 24May 25Nov 25Apr 26Oct 26

Open-market buys above the line and sales below, in dollars.

Congress and officials

No member of Congress or official has disclosed a trade in it.

Insiders

Buy orders, 12 months5
Sale orders, 12 months0
Buyers · sellers2 · 0
WhoDidSharesTraded
Ivor ElrifiChief Executive Officerbought237,616at $1.005 Aug 2026filed 6 Aug 2026
Ivor ElrifiChief Executive Officerbought83,807at $0.974 Aug 2026filed 6 Aug 2026
Ivor ElrifiChief Executive Officerbought667,000at $1.003 Aug 2026filed 5 Aug 2026
Gabriele M. CerroneDirector, 10% ownerbought42,357at $0.9921 Jul 2026filed 7 Aug 2026
Gabriele M. CerroneDirector, 10% ownerbought15,000at $1.1112 Jun 2026filed 7 Aug 2026

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders31-1 on the quarter
New · exited6 · 7
Reported value$3.0M

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

ManagerSharesChange
Dauntless Investment Group, LLCreduced · filed 13 Aug 20261,162,000$1.5M-1,003,231−46.3%
Mid-American Wealth Advisory Group, Inc.new · filed 16 Jul 2026323,240$414K+323,240
Zhang Financial LLCadded · filed 30 Jul 2026125,950$161K+14,050+12.6%
GOLDMAN SACHS GROUP INCadded · filed 14 Aug 2026119,238$153K+43,578+57.6%
CITADEL ADVISORS LLCadded · filed 14 Aug 202680,222$103K+45,128+128.6%
Focus Partners Wealthunchanged · filed 12 Aug 202679,365$102K00.0%
GEODE CAPITAL MANAGEMENT, LLCunchanged · filed 12 Aug 202678,204$100K00.0%
UBS Group AGreduced · filed 13 Aug 202672,880$93K-22,820−23.8%
HSBC HOLDINGS PLCunchanged · filed 14 Aug 202662,437$78K00.0%
MORGAN STANLEYadded · filed 13 Aug 202653,656$69K+1,500+2.9%
31 Mar 2023 – 30 Jun 2026
162431Mar 23Dec 23Dec 24Sep 25Jun 26

News

Everyone who traded it

Ivor Elrifi Company insiderChief Executive Officer · last 15 Aug 20263 · 0
Gabriele M. Cerrone Company insiderDirector, 10% owner · last 21 Jul 20262 · 0

Same industry

MRNA ModernaLeading+154%
ENTX Entera BioLeading+49%
XNCR XencorLeading+32%

Distance from each stock’s own 150-day average.

Government contracts

No federal award is tied to it.

From its SEC filings

Share count trendFY 2025 · to 31 Dec 20258.1%

Analyst forecasts

No analyst forecasts yet.